These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18003971)

  • 1. Methicillin-resistant Staphylococcus aureus infections.
    Abrahamian FM; Moran GJ
    N Engl J Med; 2007 Nov; 357(20):2090; author reply 2090. PubMed ID: 18003971
    [No Abstract]   [Full Text] [Related]  

  • 2. Elimination of a community-acquired methicillin-resistant Staphylococcus aureus infection in a nurse with atopic dermatitis.
    Roesch A; Linde HJ; Landthaler M; Vogt T
    Arch Dermatol; 2005 Dec; 141(12):1520-2. PubMed ID: 16365252
    [No Abstract]   [Full Text] [Related]  

  • 3. Trimethoprim-sulfamethoxazole or clindamycin for treatment of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Hyun DY; Mason EO; Forbes A; Kaplan SL
    Pediatr Infect Dis J; 2009 Jan; 28(1):57-9. PubMed ID: 19057459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on the characterization of Staphylococcus aureus skin infections in a pediatric dermatology tertiary health care outpatient facility: antibiotic susceptibility patterns and decreased methicillin resistance.
    Diamantis ML; Ortega-Loayza AG; Morrell DS
    J Am Acad Dermatol; 2011 Feb; 64(2):440-1. PubMed ID: 21238834
    [No Abstract]   [Full Text] [Related]  

  • 5. Comment: Trimethoprim/sulfamethoxazole for treatment of severe Staphylococcus aureus infections.
    Hmouda H; Jemni L
    Ann Pharmacother; 2004 Nov; 38(11):1970-1; author reply 1971-2. PubMed ID: 15466908
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized controlled trial of trimethoprim-sulfamethoxazole for uncomplicated skin abscesses in patients at risk for community-associated methicillin-resistant Staphylococcus aureus infection.
    Schmitz GR; Bruner D; Pitotti R; Olderog C; Livengood T; Williams J; Huebner K; Lightfoot J; Ritz B; Bates C; Schmitz M; Mete M; Deye G
    Ann Emerg Med; 2010 Sep; 56(3):283-7. PubMed ID: 20346539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection.
    Proctor RA
    Clin Infect Dis; 2008 Feb; 46(4):584-93. PubMed ID: 18197761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methicillin-resistant Staphylococcus aureus: a community concern.
    Hedge DD
    S D Med; 2006 Oct; 59(10):433, 435. PubMed ID: 17124921
    [No Abstract]   [Full Text] [Related]  

  • 9. Trimethoprim/sulfamethoxazole for treatment of severe Staphylococcus aureus infections.
    Adra M; Lawrence KR
    Ann Pharmacother; 2004 Feb; 38(2):338-41. PubMed ID: 14742775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Lawrence KR; Golik MV; Davidson L
    Am J Ther; 2009; 16(4):333-8. PubMed ID: 19617720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus.
    Grim SA; Rapp RP; Martin CA; Evans ME
    Pharmacotherapy; 2005 Feb; 25(2):253-64. PubMed ID: 15767239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of MRSA infections with older molecules: a reasonable option for investigation.
    Hmouda H; Ben Salem C; Bouraoui K; Jemni L
    Arch Intern Med; 2007 Jun; 167(11):1207-8; author reply 1208-9. PubMed ID: 17563034
    [No Abstract]   [Full Text] [Related]  

  • 13. Methicillin-resistant Staphylococcus aureus: an update for the dermatologist, Part 3: Clinical management.
    Kil EH; Heymann WR; Weinberg JM
    Cutis; 2008 Apr; 81(4):327-35. PubMed ID: 18491480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caution when reconsidering empiric antimicrobial therapy for methicillin-resistant Staphylococcus aureus skin and soft-tissue infections.
    da Silva LV; Zavascki AP; de Souza MV; Marcadenti A
    Am J Surg; 2008 Oct; 196(4):618-9. PubMed ID: 18809069
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of severe infections caused by Staphylococcus aureus: a change in the vancomycin paradigm?
    Aranha Camargo LF
    Shock; 2008 Oct; 30 Suppl 1():67-9. PubMed ID: 18704006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noncardiogenic pulmonary edema in a patient receiving vancomycin and oxycodone-acetaminophen.
    Smolarz BG; Ross J; Sachinwalla E; Marcus A; Abazia DT
    Ann Allergy Asthma Immunol; 2008 Jun; 100(6):623-4. PubMed ID: 18592834
    [No Abstract]   [Full Text] [Related]  

  • 17. Staphylococcus aureus bloodstream infections: definitions and treatment.
    Corey GR
    Clin Infect Dis; 2009 May; 48 Suppl 4():S254-9. PubMed ID: 19374581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of community-acquired methicillin resistant Staphylococcus aureus in the inpatient population.
    Bulchandani D; Comes I; Nachnani J; Al-Hihi E; Bix J; Foxworth J
    Mo Med; 2008; 105(6):510-3. PubMed ID: 19052013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment on: Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus.
    Hmouda H; Ben Salem C; Bouraoui K; Jemni L
    J Antimicrob Chemother; 2006 Dec; 58(6):1307; author reply 1307-8. PubMed ID: 17056611
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of methicillin-resistant Staphylococcus aureus (MRSA) skin infections and MRSA colonization.
    Terushkin V; Brownell I
    J Drugs Dermatol; 2008 Jun; 7(6):597-601. PubMed ID: 18561595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.